Skip to content

Long-QT Syndrome Induced by the Antiaddiction Drug Ibogaine

Dianne W. M. Hoelen, Wilko Spiering, Gerlof D. Valk

New England Journal of Medicine January 14, 2009 DOI: 10.1056/nejmc0804248 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case study Case report Peer reviewed
Sample size 1
Population A 31-year-old woman
Intervention Ibogaine
Dose 3.5 g
Topics Ibogaine
Citations 48
Key findings A single 3.5-g dose of ibogaine was associated with a seizure-like attack and severe QT prolongation (548 msec) with ventricular arrhythmias, indicating significant cardiac risk.

Abstract

A 31-year-old woman was admitted to the emergency department because of a seizure-like attack after a single 3.5-g dose of ibogaine. ECG showed a severe prolonged-QT interval of 548 msec and ventri...

Comparable studies

Other case reports and case series on ibogaine for addiction, most cited first.

Study Year Design Participants
A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder. 31-year-old male military veteran with moderate alcohol use disorder 2018 Case study n = 1
Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report. 37-year-old female with severe opioid use disorder 2016 Case study n = 1
Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias. 34-year-old white woman with heroin and cocaine use disorder 2019 Case study n = 1
Novel treatment of opioid use disorder using ibogaine and iboga in two adults Individuals with opioid use disorder accessing ibogaine through private unregulated... 2020 Case series n = 2
Risk management in a global market of alternative addiction care: a case study of the ibogaine medical subculture 2025 Case study

Explore topics

By condition and practice